Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Carew

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|April 11, 2012
Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanismKevin R Kelly, Steffan T Nawrocki, Claudia M Espitia, et al.
Plos One|February 2, 2012
ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinomaJennifer S Carew, Juan A Esquivel, Claudia M Espitia, et al.
Clinical and Translational Medicine|April 24, 2024
Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinibSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
Cancers|February 16, 2020
ABCG2 Overexpression Contributes to Pevonedistat ResistanceRishil J Kathawala, Claudia M Espitia, Trace M Jones, et al.
Diabetes Care|November 17, 2021
Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid TrialRachel A Warren, Allie S Carew, Pantelis Andreou, et al.
Blood|March 17, 2007
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistanceJennifer S Carew, Steffan T Nawrocki, Charissa N Kahue, et al.
Science (New York, N.Y.)|March 3, 2007
LRP6 mutation in a family with early coronary disease and metabolic risk factorsArya Mani, Jayaram Radhakrishnan, He Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorderArya Mani, Jayaram Radhakrishnan, Anita Farhi, et al.
Blood Reviews|May 1, 2018
Blocking "don't eat me" signal of CD47-SIRPα in hematological malignancies, an in-depth reviewAtlantis Russ, Anh B Hua, William R Montfort, et al.
Blood|July 22, 2008
Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHASteffan T Nawrocki, Jennifer S Carew, Kirsteen H Maclean, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|April 11, 2012
Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanismKevin R Kelly, Steffan T Nawrocki, Claudia M Espitia, et al.
Plos One|February 2, 2012
ELR510444 inhibits tumor growth and angiogenesis by abrogating HIF activity and disrupting microtubules in renal cell carcinomaJennifer S Carew, Juan A Esquivel, Claudia M Espitia, et al.
Clinical and Translational Medicine|April 24, 2024
Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinibSteffan T Nawrocki, Claudia M Espitia, Maria Janina Carrera Espinoza, et al.
Cancers|February 16, 2020
ABCG2 Overexpression Contributes to Pevonedistat ResistanceRishil J Kathawala, Claudia M Espitia, Trace M Jones, et al.
Diabetes Care|November 17, 2021
Haptoglobin Phenotype Modifies the Effect of Fenofibrate on Risk of Coronary Event: ACCORD Lipid TrialRachel A Warren, Allie S Carew, Pantelis Andreou, et al.
Blood|March 17, 2007
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistanceJennifer S Carew, Steffan T Nawrocki, Charissa N Kahue, et al.
Science (New York, N.Y.)|March 3, 2007
LRP6 mutation in a family with early coronary disease and metabolic risk factorsArya Mani, Jayaram Radhakrishnan, He Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorderArya Mani, Jayaram Radhakrishnan, Anita Farhi, et al.
Blood Reviews|May 1, 2018
Blocking "don't eat me" signal of CD47-SIRPα in hematological malignancies, an in-depth reviewAtlantis Russ, Anh B Hua, William R Montfort, et al.
Blood|July 22, 2008
Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHASteffan T Nawrocki, Jennifer S Carew, Kirsteen H Maclean, et al.
Pageof 11